Monday, September 24, 2012

Health - Google News: Novartis's drug reduces heart failure deaths: study - Reuters

Health - Google News
Google News
Novartis's drug reduces heart failure deaths: study - Reuters
Sep 24th 2012, 08:09


Novartis's drug reduces heart failure deaths: study
Reuters
| ZURICH (Reuters) - Novartis's investigational medicine RLX030 reduced the number of deaths in patients with acute heart failure, the drugmaker said on Monday based on the results of a late-stage trial. RLX030 is form of the human hormone relaxin-2.
Novartis: Phase III Trial Shows RLX030 Reduces Deaths In Heart Failure PatientsRTT News
NOVARTIS AG : Results from Novartis Phase III study show that RLX030 reduced ...4-traders
Results from Novartis Phase III study show that RLX030 reduced deaths in ...MarketWatch (press release)

all 20 news articles »

You are receiving this email because you subscribed to this feed at blogtrottr.com.

If you no longer wish to receive these emails, you can unsubscribe from this feed, or manage all your subscriptions

0 comments:

Post a Comment

Twitter Delicious Facebook Digg Stumbleupon Favorites More